AJMC November 21, 2024
Mary Caffrey

Key Takeaways

  • Precision medicine has replaced aggressive drug therapies, improving cancer outcomes and patient quality of life.
  • Ageism in oncology leads to underrepresentation of older patients in clinical trials and exclusion from intensive therapies.
  • City of Hope integrates supportive and integrative oncology, focusing on holistic care to enhance patient well-being.
  • Expanding access to comprehensive assessments and innovative therapies aims to democratize cancer care.
  • Maintaining consistent, high-quality care across multiple sites involves clinical trials, genomic testing, and standardized pathways.

Institute for Value-Based Medicine event with City of Hope.

To hear Joseph Alvarnas, MD, tell it, the fight against cancer was once seen as a mission to create increasingly powerful drugs—as much as the human body could handle—and pummel the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Patient / Consumer, Payment Models, Pharma / Biotech, Precision Medicine, Provider, Value Based
Related Articles:
70% of Americans want primary care providers to address mental health
Food as Medicine: Diet’s Role in Parkinson’s Disease
ACHC Awards DispatchHealth With First In-Home Hospital Care Accreditation
Increasing the Longevity of Accountability, Designing Cooperative Models, and Transferring Risk Across a Lifetime of Accountable Care
Advancing Equitable Access to Elevate Value-Based Cancer Care

Share This Article